130 related articles for article (PubMed ID: 11322655)
41. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II.
Jansen H; Chu G; Ehnholm C; Dallongeville J; Nicaud V; Talmud PJ
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):303-8. PubMed ID: 9974411
[TBL] [Abstract][Full Text] [Related]
42. Cholesteryl ester transfer protein mutations, protein activity and HDL-cholesterol concentration.
Hill SA; Thomson C; McQueen MJ
Clin Chem Lab Med; 1998 Aug; 36(8):629-32. PubMed ID: 9806474
[TBL] [Abstract][Full Text] [Related]
43. Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population.
Hill SA; Nazir DJ; Jayaratne P; Bamford KS; McQueen MJ
Clin Biochem; 1997 Jul; 30(5):413-8. PubMed ID: 9253518
[TBL] [Abstract][Full Text] [Related]
44. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.
Zhong S; Sharp DS; Grove JS; Bruce C; Yano K; Curb JD; Tall AR
J Clin Invest; 1996 Jun; 97(12):2917-23. PubMed ID: 8675707
[TBL] [Abstract][Full Text] [Related]
45. The effects of the cholesterol ester transfer protein gene and environmental factors on the plasma high density lipoprotein cholesterol levels in the Korean population.
Song GJ; Han GH; Chae JJ; Namkoong Y; Lee HK; Park YB; Lee CC
Mol Cells; 1997 Oct; 7(5):615-9. PubMed ID: 9387148
[TBL] [Abstract][Full Text] [Related]
46. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients.
Jansen H; Verhoeven AJ; Weeks L; Kastelein JJ; Halley DJ; van den Ouweland A; Jukema JW; Seidell JC; Birkenhäger JC
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2837-42. PubMed ID: 9409263
[TBL] [Abstract][Full Text] [Related]
47. Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population.
Fang DZ; Liu BW
Atherosclerosis; 2002 Apr; 161(2):417-24. PubMed ID: 11888526
[TBL] [Abstract][Full Text] [Related]
48. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity.
Su Z; Zhang S; Nebert DW; Zhang L; Huang D; Hou Y; Liao L; Xiao C
J Lipid Res; 2002 Oct; 43(10):1595-601. PubMed ID: 12364543
[TBL] [Abstract][Full Text] [Related]
49. A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients.
Kimura H; Gejyo F; Yamaguchi T; Suzuki S; Imura T; Miyazaki R; Arakawa M
J Am Soc Nephrol; 1999 Feb; 10(2):294-9. PubMed ID: 10215328
[TBL] [Abstract][Full Text] [Related]
50. A common mutation of cholesteryl ester transfer protein gene in dialysis patients.
Kimura H; Gejyo F; Suzuki S; Yamaguchi T; Imura T; Miyazaki R; Ei K; Ei I; Oda M; Miyakawa Y; Arakawa M
Kidney Int Suppl; 1999 Jul; 71():S186-9. PubMed ID: 10412772
[TBL] [Abstract][Full Text] [Related]
51. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia.
Inazu A; Koizumi J; Haraki T; Yagi K; Wakasugi T; Takegoshi T; Mabuchi H; Takeda R
Hum Genet; 1993 Mar; 91(1):13-6. PubMed ID: 8454281
[TBL] [Abstract][Full Text] [Related]
52. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
[TBL] [Abstract][Full Text] [Related]
53. Human hepatic lipase mutations and polymorphisms.
Hegele RA; Tu L; Connelly PW
Hum Mutat; 1992; 1(4):320-4. PubMed ID: 1301939
[TBL] [Abstract][Full Text] [Related]
54. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.
Allayee H; Dominguez KM; Aouizerat BE; Krauss RM; Rotter JI; Lu J; Cantor RM; de Bruin TW; Lusis AJ
J Lipid Res; 2000 Feb; 41(2):245-52. PubMed ID: 10681408
[TBL] [Abstract][Full Text] [Related]
55. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity.
Deeb SS; Peng R
J Lipid Res; 2000 Jan; 41(1):155-8. PubMed ID: 10627514
[TBL] [Abstract][Full Text] [Related]
56. The rat hepatic lipase gene is expressed into two different proteins in liver, adrenals and ovaries.
Verhoeven AJ; Jansen H
Z Gastroenterol; 1996 Jun; 34 Suppl 3():54-5. PubMed ID: 8767462
[TBL] [Abstract][Full Text] [Related]
57. Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
Andersen RV; Wittrup HH; Tybjaerg-Hansen A; Steffensen R; Schnohr P; Nordestgaard BG
J Am Coll Cardiol; 2003 Jun; 41(11):1972-82. PubMed ID: 12798568
[TBL] [Abstract][Full Text] [Related]
58. Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence.
Grundy SM; Vega GL; Otvos JD; Rainwater DL; Cohen JC
J Lipid Res; 1999 Feb; 40(2):229-34. PubMed ID: 9925651
[TBL] [Abstract][Full Text] [Related]
59. Relationship between serum HDL-C levels and common genetic variants of the endothelial lipase gene in Japanese school-aged children.
Yamakawa-Kobayashi K; Yanagi H; Endo K; Arinami T; Hamaguchi H
Hum Genet; 2003 Sep; 113(4):311-5. PubMed ID: 12884003
[TBL] [Abstract][Full Text] [Related]
60. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.
Hegele RA; Harris SB; Brunt JH; Young TK; Hanley AJ; Zinman B; Connelly PW
Atherosclerosis; 1999 Sep; 146(1):153-60. PubMed ID: 10487498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
